Meyer Handelman Company’s Novartis NVS Stock Holding History

Meyer Handelman Company’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$354K	Buy	+2,320	New	+$356K	0.01%	192

Other funds holding NVS

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Meyer Handelman Company's NVS Position: Q1 2026 in Review

Meyer Handelman Company opened a new position in Novartis (NVS) in Q1 2026: 2,320 shares worth $354K. The stake represents 0.01% of the portfolio and ranks #192 among its holdings.

1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

Meyer Handelman Company held 2,320 shares of Novartis worth $354K as of Q1 2026.
Novartis was a new Meyer Handelman Company position in Q1 2026.
Novartis made up 0.01% of Meyer Handelman Company's portfolio in Q1 2026, its #192 holding.
1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Meyer Handelman Company's 13F filing for Q1 2026, filed 20 Apr 2026.